ARTHEx Biotech Appoints Christian Freitag as Chief Medical Officer
PRIVATENov 04, 2026
Position
Chief Medical Officer
Company
ARTHEx Biotech
Christian Freitag
BiotechnologyHealth CareTherapeutics
Description
ARTHEx Biotech has announced the appointment of Christian (Chris) Freitag, M.D., as Chief Medical Officer. Dr. Freitag brings over 20 years of experience in clinical development and medical strategy within the biopharmaceutical industry.
Who to call at ARTHEx Biotech, and when
A new leader at ARTHEx Biotech brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day ARTHEx Biotech raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at ARTHEx Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARTHEx Biotech. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
ARTHEx Biotech
About
ARTHEx Biotech is a spin-off biotech company from the University of Valencia (Spain) focused on the research and development of novel oligonucleotide therapies that modulate microRNA to treat diseases with unmet medical needs.
ARTHEx has developed its proprietary technology, the ENTRY ™ platform, that allows fast and flexible development of investigational miR-modulating oligonucleotides that are designed to enter relevant tissues in pharmacological quantities, in order to treat diseases in which microRNAs play a key role.
The first investigational product from this platform is ATX-01, an antimiR in preclinical development for Myotonic Dystrophy Type 1 (DM1). DM1 is an orphan disease affecting more than 900,000 people worldwide (estimated prevalence 1/8,000) with no cure, nor approved treatment to date. ATX-01 is a first-in-class disease-modifying therapy that addresses the cause of DM1 with a dual and unique mechanism of action, which targets micro-RNA-23b a key factor in the disease pathogenesis.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARTHEx Biotech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
